The MedTech Funding Mandate (MTFM) policy launched on 1 April 2021. The guidance for 2021/22 is published here.

In 2021/22 the policy will support devices, diagnostics or digital products that:

  • are effective: demonstrated through positive NICE guidance;
  • deliver material savings to the NHS: the benefits of the innovation are over £1 million over five years for the population of England;
  • are cost-saving in-year: NICE modelling demonstrates a net saving in the first 12 months of implementing the technology;
  • are affordable to the NHS: the budget impact should not exceed £20 million, in any of the first three years.

 

To minimise burden on the NHS at this time, it was agreed that for the first year of the policy only, technologies must have also been previously supported by the Innovation Technology Payment.

The technologies that will be supported by the policy in 2021/22 are:

  1. Placental growth factor based testing (PlGF) – a blood test to rule out pre-eclampsia in pregnant women. Find out more about PlGF in this short film with Guy Checketts, Interim Director of Strategic and Industry Partnerships at Oxford AHSN and National AHSN Lead for PlGF-based testing.
  2. SecurAcath – for securing percutaneous catheters. Find out more about SecurAcath in this short film with Jennifer Miller, National Clinical Specialist at Aquilant Healthcare 21, the UK distributor of SecurAcath.
  3. HeartFlow – creates a 3D model of a patient’s coronary arteries and assesses the extent and location of blockages. Find out more about HeartFlow in this short film with Gina McDonald-Main, Vice President Government Affairs at HeartFlow.
  4. gammaCore – a handheld device which alleviates the symptoms of severe cluster headaches. Find out more about gammaCore in this short film with Iain Strickland, Vice President Global Sales and Strategy at electroCore.

 

The NHS Accelerated Access Collaborative (AAC) team will regularly review NICE guidance on medical technologies and diagnostics to identify medical devices, diagnostics and digital products which have been recommended by NICE and are likely to meet the MedTech Funding Mandate criteria in the following year, and highlight these to providers and commissioners.

Together with technology suppliers, the AAC will work with patients and delivery partners, the AHSN Network, to support NHS organisations to implement these innovations, to understand local and regional issues and to share learning from NHS organisations who have already implemented the innovations. This will help identify barriers to their uptake, such as duplicative procurement processes.

The AAC expects hospitals and commissioning organisations to comply with the policy guidance where appropriate. The AHSN delivery partners will work closely with commissioners, providers, clinicians, patient groups and others, to understand the impact of the policy and support its development.

Find out more about the MTFM in this series of short films recorded at the May 2021 AAC briefing, and access the presentation slides.

Watch Matt Whitty, Director of Innovation, Research and Life Sciences (IRLS) and Chief Executive of AAC discuss the MTFM.

Watch Phil Jennings, Chief Executive of Innovation Agency and Chief Officer Lead at the AHSN Network for MTFM explain how AHSNs can help providers deliver the policy.

Find out more about PlGF in this short film with Guy Checketts, Interim Director of Strategic and Industry Partnerships at Oxford AHSN and National AHSN Lead for PlGF-based testing.

Find out more about SecurAcath in this short film with Jennifer Miller, National Clinical Specialist at Aquilant Healthcare 21, the UK distributor of SecurAcath.

Find out more about HeartFlow in this short film with Gina McDonald-Main, Vice President Government Affairs at HeartFlow.

Find out more about gammaCore in this short film with Iain Strickland, Vice President Global Sales and Strategy at electroCore.

Find out more about the financial mechanisms that need to be put in place to ensure that all eligible patients can access the MTFM technologies in this short film with Sarah Tyres, Senior Innovation Manager, Innovation, Research and Life Sciences (IRLS).

Find out more about the MTFM supply chain with Sarah Young, Regional Supply Chain Manager, NHS Supply Chain

Watch the Q&A section of the briefing.

Watch the next steps section of the briefing with Matt Whitty, Director of Innovation, Research and Life Sciences (IRLS) and Chief Executive of AAC.

Providers wishing to implement any of the supported technologies, please contact your regional AHSN, or alternatively contact the innovation team in the AAC via AAC.innovation@nhs.net, citing ‘MTFM’ in the subject line.